PepsiCo faces pressure to meet targets amid GLP-1 drug threat
PepsiCo is under pressure to meet growth and margin targets set after Elliott Investment Management took a stake, as GLP-1 weight-loss drugs pose a threat to its snack and drink business. The company's North America business is facing volume contractions due to higher input costs and inflation, with core operating marg